The wording is ambiguous. I hope the letter is clearer!
I expect that the intent in "grant the network an exclusive, no-cost license to use ResAppDx in their hospitals in Germany for six months" is in the words "in Germany". Otherwise we're globally hamstrung for half a year!
The wording is ambiguous. I hope the letter is clearer! I expect...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #